Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2012-05-24 08:00 |
VIVALIS : INITIATION D'UN ESSAI CLINIQUE DE PHASE II POUR UN VACCIN GRIPPE HUMA…
|
French | 80.9 KB | ||
| 2012-05-24 08:00 |
VIVALIS: PHASE II CLINICAL TRIAL FOR A HUMAN INFLUENZA VACCINE INITIATED
|
English | 71.4 KB | ||
| 2012-05-14 07:30 |
VIVALIS : ASSEMBLEE DES ACTIONNAIRES 4 JUIN 2012 MISE A DISPOSITION DES DOCUMEN…
|
English | 75.3 KB | ||
| 2012-05-09 08:04 |
VIVALIS ET BIODIEM INITIENT UNE COLLABORATION POUR TESTER LA PRODUCTION DU VECT…
|
French | 124.2 KB | ||
| 2012-05-09 08:01 |
VIVALIS AND BIODIEM BEGIN COLLABORATION TO TEST PRODUCTION OF THE LAIV VECTOR …
|
English | 113.3 KB | ||
| 2012-05-02 17:58 |
VIVALIS :ACTIONS ET DROITS DE VOTE AVRIL 2012
|
English | 132.1 KB | ||
| 2012-04-27 07:30 |
VIVALIS : MISE A DISPOSITION DU DOCUMENT DE REFERENCE 2011
|
English | 234.8 KB | ||
| 2012-04-26 17:40 |
VIVALIS : Chiffre d'affaires T1 2012 et trésorerie consolidée solide
|
French | 92.0 KB | ||
| 2012-04-26 17:40 |
VIVALIS: first quarter 2012 revenues (IFRS) and a consolidated cash position
|
English | 55.0 KB | ||
| 2012-04-04 17:45 |
VIVALIS : ACTIONS ET DROITS DE VOTE MARS 2012
|
English | 132.1 KB | ||
| 2012-03-29 17:41 |
VIVALIS :Résultats 2011 : poursuite d'un développement soutenu
|
French | 110.5 KB | ||
| 2012-03-29 17:41 |
VIVALIS 2011 results: continuing growth momentum
|
English | 107.4 KB | ||
| 2012-03-13 17:40 |
VIVALIS annonce la signature d'un accord de collaboration et de licence commer…
|
French | 54.3 KB | ||
| 2012-03-13 17:40 |
VIVALIS announces the signature of a broad collaboration agreement and commerc…
|
English | 79.8 KB | ||
| 2012-03-02 17:45 |
VIVALIS :ACTIONS ET DROITS DE VOTE
|
English | 6.8 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
